In a preliminary study (85), EEG abnormalities during sleep were associated with cerebrospinal fluid biomarkers, particularly hyperphosphorylated tau protein levels, suggesting the presence of preclinical AD. This evidence concerns the gene MAPT and Alzheimer disease.